U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606599) titled 'A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure' on May 19.
Brief Summary: This trial is a registrational Phase III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-M07D1 in patients with HER2-expressing locally advanced or metastatic biliary tract cancer after platinum-containing chemotherapy failure.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Biliary Tract Cancer
Intervention:
DRUG: BL-M07D1
Administration by intravenous in...